siRNA therapy decreases triglycerides in individuals along with unusual ailment

.STUDY HIGHLIGHT.19 September 2024.

Plozasiran minimized triglyceride levels through 80% as well as decreased the threat of pancreatitis in individuals along with consistent chylomicronemia, with or without a hereditary medical diagnosis.